Dr. Laszlo Mechtler, MD, FAAN, FEAN, FAHS, FASN, FAAN is an internationally distinguished neurologist, neuro‑oncologist, and healthcare executive whose career has been defined by clinical excellence, visionary leadership, and a relentless commitment to innovation in neuroscience. As President of the Dent Neurologic Institute—the largest outpatient neuroscience center in the United States—Dr. Mechtler oversees a comprehensive ecosystem of neurologic care, advanced imaging, and transformative therapeutics. Under his leadership, Dent has become a global benchmark for integrating cutting‑edge diagnostics with patient‑centered clinical research.
Dr. Mechtler serves as Director of the Dent Headache Center, Neuro‑Oncology Center, and Cannabis Clinic, and is Chief of Neurology and Neuro‑Oncology at Roswell Park Comprehensive Cancer Center. He also leads the MIND: Mechtler Institute for Neurologic Disorders in Budapest, Hungary, extending his influence across continents and fostering international collaboration in neurologic research and education.
A prolific clinician‑scientist, Dr. Mechtler directs more than 30 active clinical trials spanning headache medicine, neuro‑oncology, neuroimaging, and cannabinoid therapeutics. He is widely recognized for his expertise in refractory headache disorders, complex neuro‑oncologic conditions, and the medical application of cannabinoids. He was among the first researchers worldwide to publish large‑scale retrospective studies on the safety and efficacy of medical cannabis for neurologic disorders—work that led to the development of Percise, a clinically informed cannabinoid therapy line.
Dr. Mechtler’s academic contributions include numerous peer‑reviewed publications, book chapters, and multiple guest‑edited issues of Neurologic Clinics, particularly on the evolution of neuroimaging. His commitment to mentorship is reflected in his long‑standing leadership of the Hungarian Medical Association of America student exchange program and his service on advisory boards for NeuroDiscovery AI and Genomate Health.
Throughout his career, Dr. Mechtler has held prestigious leadership roles, including two terms as President of the American Society of Neuroimaging and President of the Hungarian Medical Association of America. He has served on the boards of the International Headache Society, NeuroDiscovery AI, and Genomate Health. In recognition of his extraordinary contributions to neuroimaging and neuroscience, he was honored with the ASN Lifetime Achievement Award in 2026—a testament to his enduring impact on evidence‑based medicine and his unwavering dedication to improving the lives of patients with complex neurologic disorders.
AdvisorPast President
